Effects of darbepoetin α on right and left ventricular systolic and diastolic function in anemic patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy
- 30 April 2008
- journal article
- research article
- Published by Elsevier BV in American Heart Journal
- Vol. 155 (4), 751.e1-751.e7
- https://doi.org/10.1016/j.ahj.2008.01.016
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Effects of β-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal anemia syndromeAmerican Heart Journal, 2007
- Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemiaAmerican Heart Journal, 2006
- Every 3 weeks dosing with darbepoetin alfa: A new paradigm in anaemia managementCancer Treatment Reviews, 2006
- Erythropoietin Enhances Neovascularization of Ischemic Myocardium and Improves Left Ventricular Dysfunction After Myocardial Infarction in DogsJournal of the American College of Cardiology, 2006
- Erythropoietin: Repair of the Failing HeartJournal of the American College of Cardiology, 2006
- Anemia in Chronic Heart FailureCirculation, 2006
- The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMETEuropean Heart Journal, 2006
- Anemia as a risk factor and therapeutic target in heart failureJournal of the American College of Cardiology, 2004
- Erythropoietin resistance: the role of inflammation and pro‐inflammatory cytokinesNephrology Dialysis Transplantation, 2002
- Relation of left ventricular shape, function and wall stress in manThe American Journal of Cardiology, 1974